Skip to main content
Top
Published in: Inflammation 5/2017

01-10-2017 | ORIGINAL ARTICLE

Effects of Carvacrol on Survival, Mesenteric Blood Flow, Aortic Function and Multiple Organ Injury in a Murine Model of Polymicrobial Sepsis

Authors: Erdem Kamil Ozer, Mustafa Tugrul Goktas, Aysun Toker, Hulagu Bariskaner, Ceyhan Ugurluoglu, Alper Bektas Iskit

Published in: Inflammation | Issue 5/2017

Login to get access

Abstract

Carvacrol (CRV) has strong cytoprotective, antioxidant, and anti-inflammatory properties. We aimed to demonstrate the possible protective effects of CRV on survival, mesenteric artery blood flow (MBF), vascular reactivity, and oxidative and inflammatory injuries in a murine model of polymicrobial sepsis induced by cecal ligation and puncture (CLP). Wistar rats were allocated into the following four groups: Sham, CLP, Sham + CRV, and CLP + CRV. The animals were orally administered with CRV (80 mg/kg/day) or vehicle (corn oil; 1 mL/kg/day) for 7 days. At the eighth day, Sham or CLP procedure was applied. Twenty hours after the operations, MBF and contractile responses of isolated aortic preparations to phenylephrine were measured. Tissue samples were obtained for biochemical and histopathological assessments. Additionally, survival rates were recorded throughout 96 h. CRV administration improved the mesenteric perfusion, contractile function of aorta, and survival after CLP. CRV substantially prevented the elevations in the levels of LDH, BUN, Cr, and inflammatory cytokines (tumor necrosis factor-alpha, interleukin-1 beta and interleukin-6) but could not prevent the elevations of AST and ALT after CLP. The decreased liver, kidney, and spleen glutathione levels and increased liver, kidney, lung, and spleen malondialdehyde levels induced by CLP were substantially restored by CRV. Also, histopathological protective effects of CRV on multiple organ damage due to CLP were observed. CRV possesses strong ameliorative effects on sepsis due to its protective effects on mesenteric perfusion and aortic function and its antioxidative and anti-inflammatory effects.
Literature
1.
go back to reference Gaieski, D.F., J.M. Edwards, M.J. Kallan, and B.G. Carr. 2013. Benchmarking the incidence and mortality of severe sepsis in the United States*. Critical Care Medicine 41: 1167–1174.CrossRefPubMed Gaieski, D.F., J.M. Edwards, M.J. Kallan, and B.G. Carr. 2013. Benchmarking the incidence and mortality of severe sepsis in the United States*. Critical Care Medicine 41: 1167–1174.CrossRefPubMed
2.
go back to reference Vincent, J.L., J.C. Marshall, S.A. Namendys-Silva, B. Francois, I. Martin-Loeches, J. Lipman, K. Reinhart, M. Antonelli, P. Pickkers, H. Njimi, et al. 2014. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. The Lancet Respiratory Medicine 2: 380–386.CrossRefPubMed Vincent, J.L., J.C. Marshall, S.A. Namendys-Silva, B. Francois, I. Martin-Loeches, J. Lipman, K. Reinhart, M. Antonelli, P. Pickkers, H. Njimi, et al. 2014. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. The Lancet Respiratory Medicine 2: 380–386.CrossRefPubMed
3.
go back to reference Balzan, S., Quadros C. de Almeida, R. de Cleva, B. Zilberstein, and I. Cecconello. 2007. Bacterial translocation: overview of mechanisms and clinical impact. Journal of Gastroenterology and Hepatology 22: 464–471.CrossRefPubMed Balzan, S., Quadros C. de Almeida, R. de Cleva, B. Zilberstein, and I. Cecconello. 2007. Bacterial translocation: overview of mechanisms and clinical impact. Journal of Gastroenterology and Hepatology 22: 464–471.CrossRefPubMed
4.
go back to reference Koh, I.H., J.L. Menchaca-Diaz, S.H. Farsky, A.F. Siqueira, M. Ruiz-Silva, P. Juliana, U. Fagundes-Neto, M.B. Morais, and R.M. Silva. 2002. Injuries to the mesenteric microcirculation due to bacterial translocation. Transplantation Proceedings 34: 1003–1004.CrossRefPubMed Koh, I.H., J.L. Menchaca-Diaz, S.H. Farsky, A.F. Siqueira, M. Ruiz-Silva, P. Juliana, U. Fagundes-Neto, M.B. Morais, and R.M. Silva. 2002. Injuries to the mesenteric microcirculation due to bacterial translocation. Transplantation Proceedings 34: 1003–1004.CrossRefPubMed
5.
go back to reference De Backer, D., D. Orbegozo Cortes, K. Donadello, and J.-L. Vincent. 2014. Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock. Virulence 5: 73–79.CrossRefPubMed De Backer, D., D. Orbegozo Cortes, K. Donadello, and J.-L. Vincent. 2014. Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock. Virulence 5: 73–79.CrossRefPubMed
6.
go back to reference Matsuda, N., and Y. Hattori. 2007. Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction. Journal of Smooth Muscle Research 43: 117–137.CrossRefPubMed Matsuda, N., and Y. Hattori. 2007. Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction. Journal of Smooth Muscle Research 43: 117–137.CrossRefPubMed
7.
go back to reference Schulte, W., Bernhagen, J., and Bucala, R. 2013. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets—an updated view. Mediators of inflammation , 2013. Schulte, W., Bernhagen, J., and Bucala, R. 2013. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets—an updated view. Mediators of inflammation , 2013.
8.
go back to reference Hubbard, W.J., M. Choudhry, M.G. Schwacha, J.D. Kerby, L.W. Rue 3rd, K.I. Bland, and I.H. Chaudry. 2005. Cecal ligation and puncture. Shock 24 (Suppl 1): 52–57.CrossRefPubMed Hubbard, W.J., M. Choudhry, M.G. Schwacha, J.D. Kerby, L.W. Rue 3rd, K.I. Bland, and I.H. Chaudry. 2005. Cecal ligation and puncture. Shock 24 (Suppl 1): 52–57.CrossRefPubMed
9.
go back to reference Iskit, A.B., and M.O. Guc. 2004. A new therapeutic approach for the treatment of sepsis. Medical Hypotheses 62: 342–345.CrossRefPubMed Iskit, A.B., and M.O. Guc. 2004. A new therapeutic approach for the treatment of sepsis. Medical Hypotheses 62: 342–345.CrossRefPubMed
10.
go back to reference Baser, K.H. 2008. Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils. Current Pharmaceutical Design 14: 3106–3119.CrossRefPubMed Baser, K.H. 2008. Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils. Current Pharmaceutical Design 14: 3106–3119.CrossRefPubMed
11.
go back to reference Burt, S. 2004. Essential oils: their antibacterial properties and potential applications in foods--a review. International Journal of Food Microbiology 94: 223–253.CrossRefPubMed Burt, S. 2004. Essential oils: their antibacterial properties and potential applications in foods--a review. International Journal of Food Microbiology 94: 223–253.CrossRefPubMed
12.
go back to reference Aristatile, B., K.S. Al-Numair, C. Veeramani, and K.V. Pugalendi. 2009. Effect of carvacrol on hepatic marker enzymes and antioxidant status in D-galactosamine-induced hepatotoxicity in rats. Fundamental & Clinical Pharmacology 23: 757–765.CrossRef Aristatile, B., K.S. Al-Numair, C. Veeramani, and K.V. Pugalendi. 2009. Effect of carvacrol on hepatic marker enzymes and antioxidant status in D-galactosamine-induced hepatotoxicity in rats. Fundamental & Clinical Pharmacology 23: 757–765.CrossRef
13.
go back to reference Guarda, A., J.F. Rubilar, J. Miltz, and M.J. Galotto. 2011. The antimicrobial activity of microencapsulated thymol and carvacrol. International Journal of Food Microbiology 146: 144–150.CrossRefPubMed Guarda, A., J.F. Rubilar, J. Miltz, and M.J. Galotto. 2011. The antimicrobial activity of microencapsulated thymol and carvacrol. International Journal of Food Microbiology 146: 144–150.CrossRefPubMed
14.
go back to reference Kara, M., S. Uslu, F. Demirci, H.E. Temel, and C. Baydemir. 2015. Supplemental carvacrol can reduce the severity of inflammation by influencing the production of mediators of inflammation. Inflammation 38: 1020–1027.CrossRefPubMed Kara, M., S. Uslu, F. Demirci, H.E. Temel, and C. Baydemir. 2015. Supplemental carvacrol can reduce the severity of inflammation by influencing the production of mediators of inflammation. Inflammation 38: 1020–1027.CrossRefPubMed
15.
go back to reference Dagli Gul, A.S., E. Fadillioglu, I. Karabulut, A. Yesilyurt, and T. Delibasi. 2013. The effects of oral carvacrol treatment against H2O2 induced injury on isolated pancreas islet cells of rats. Islets 5: 149–155.CrossRefPubMed Dagli Gul, A.S., E. Fadillioglu, I. Karabulut, A. Yesilyurt, and T. Delibasi. 2013. The effects of oral carvacrol treatment against H2O2 induced injury on isolated pancreas islet cells of rats. Islets 5: 149–155.CrossRefPubMed
16.
go back to reference Ozer, E.K., and A.B. Iskit. 2016. Effects of endothelin and nitric oxide on cardiac muscle functions in experimental septic shock model. Human & Experimental Toxicology 35: 267–275.CrossRef Ozer, E.K., and A.B. Iskit. 2016. Effects of endothelin and nitric oxide on cardiac muscle functions in experimental septic shock model. Human & Experimental Toxicology 35: 267–275.CrossRef
17.
go back to reference Yuksel, B.C., S.E. Serdar, A. Tuncel, N. Uzum, O. Ataoglu, A. Atan, S. Hengirmen, A.B. Iskit, and M.O. Guc. 2009. Effect of tempol, a membrane-permeable radical scavenger, on mesenteric blood flow and organ injury in a murine cecal ligation and puncture model of septic shock. European Surgical Research 43: 219–227.CrossRefPubMed Yuksel, B.C., S.E. Serdar, A. Tuncel, N. Uzum, O. Ataoglu, A. Atan, S. Hengirmen, A.B. Iskit, and M.O. Guc. 2009. Effect of tempol, a membrane-permeable radical scavenger, on mesenteric blood flow and organ injury in a murine cecal ligation and puncture model of septic shock. European Surgical Research 43: 219–227.CrossRefPubMed
18.
go back to reference Ozer, E.K., M.T. Goktas, I. Kilinc, H. Bariskaner, C. Ugurluoglu, and A.B. Iskit. 2017. Celecoxib administration reduced mortality, mesenteric hypoperfusion, aortic dysfunction and multiple organ injury in septic rats. Biomedicine & Pharmacotherapy 86: 583–589.CrossRef Ozer, E.K., M.T. Goktas, I. Kilinc, H. Bariskaner, C. Ugurluoglu, and A.B. Iskit. 2017. Celecoxib administration reduced mortality, mesenteric hypoperfusion, aortic dysfunction and multiple organ injury in septic rats. Biomedicine & Pharmacotherapy 86: 583–589.CrossRef
19.
go back to reference Kalea, A.Z., K. Clark, D.A. Schuschke, A.S. Kristo, and D.J. Klimis-Zacas. 2010. Dietary enrichment with wild blueberries (Vaccinium angustifolium) affects the vascular reactivity in the aorta of young spontaneously hypertensive rats. The Journal of Nutritional Biochemistry 21: 14–22.CrossRefPubMed Kalea, A.Z., K. Clark, D.A. Schuschke, A.S. Kristo, and D.J. Klimis-Zacas. 2010. Dietary enrichment with wild blueberries (Vaccinium angustifolium) affects the vascular reactivity in the aorta of young spontaneously hypertensive rats. The Journal of Nutritional Biochemistry 21: 14–22.CrossRefPubMed
20.
go back to reference Taslidere, E., Z. Dogan, H. Elbe, N. Vardi, A. Cetin, and Y. Turkoz. 2016. Quercetin protection against ciprofloxacin induced liver damage in rats. Biotechnic & Histochemistry 91: 116–121.CrossRef Taslidere, E., Z. Dogan, H. Elbe, N. Vardi, A. Cetin, and Y. Turkoz. 2016. Quercetin protection against ciprofloxacin induced liver damage in rats. Biotechnic & Histochemistry 91: 116–121.CrossRef
21.
go back to reference Andrades, M., C. Ritter, M.R. de Oliveira, E.L. Streck, J.C.F. Moreira, and F. Dal-Pizzol. 2011. Antioxidant treatment reverses organ failure in rat model of sepsis: role of antioxidant enzymes imbalance, neutrophil infiltration, and oxidative stress. Journal of Surgical Research 167: e307–e313.CrossRefPubMed Andrades, M., C. Ritter, M.R. de Oliveira, E.L. Streck, J.C.F. Moreira, and F. Dal-Pizzol. 2011. Antioxidant treatment reverses organ failure in rat model of sepsis: role of antioxidant enzymes imbalance, neutrophil infiltration, and oxidative stress. Journal of Surgical Research 167: e307–e313.CrossRefPubMed
23.
go back to reference Wang, C., A. Mansard, P. Giummelly, and J. Atkinson. 2004. Decreased aortic smooth muscle contraction in a rat model of multibacterial sepsis. Fundamental & Clinical Pharmacology 18: 679–683.CrossRef Wang, C., A. Mansard, P. Giummelly, and J. Atkinson. 2004. Decreased aortic smooth muscle contraction in a rat model of multibacterial sepsis. Fundamental & Clinical Pharmacology 18: 679–683.CrossRef
24.
go back to reference Banji, O.J., D. Banji, N. Soumya, K.K. Chilipi, C.H. Kalpana, C.H. Kranthi Kumar, and A.R. Annamalai. 2014. Combination of carvacrol with methotrexate suppresses complete Freund’s adjuvant induced synovial inflammation with reduced hepatotoxicity in rats. European Journal of Pharmacology 723: 91–98.CrossRefPubMed Banji, O.J., D. Banji, N. Soumya, K.K. Chilipi, C.H. Kalpana, C.H. Kranthi Kumar, and A.R. Annamalai. 2014. Combination of carvacrol with methotrexate suppresses complete Freund’s adjuvant induced synovial inflammation with reduced hepatotoxicity in rats. European Journal of Pharmacology 723: 91–98.CrossRefPubMed
25.
go back to reference Khosravi, A.R., and D.J. Erle. 2016. Chitin-induced airway epithelial cell innate immune responses are inhibited by Carvacrol/Thymol. PloS One 11: e0159459.CrossRefPubMedPubMedCentral Khosravi, A.R., and D.J. Erle. 2016. Chitin-induced airway epithelial cell innate immune responses are inhibited by Carvacrol/Thymol. PloS One 11: e0159459.CrossRefPubMedPubMedCentral
26.
go back to reference Arigesavan, K., and G. Sudhandiran. 2015. Carvacrol exhibits anti-oxidant and anti-inflammatory effects against 1, 2-dimethyl hydrazine plus dextran sodium sulfate induced inflammation associated carcinogenicity in the colon of Fischer 344 rats. Biochemical and Biophysical Research Communications 461: 314–320.CrossRefPubMed Arigesavan, K., and G. Sudhandiran. 2015. Carvacrol exhibits anti-oxidant and anti-inflammatory effects against 1, 2-dimethyl hydrazine plus dextran sodium sulfate induced inflammation associated carcinogenicity in the colon of Fischer 344 rats. Biochemical and Biophysical Research Communications 461: 314–320.CrossRefPubMed
27.
go back to reference Suo, L., K. Kang, X. Wang, Y. Cao, H. Zhao, X. Sun, L. Tong, and F. Zhang. 2014. Carvacrol alleviates ischemia reperfusion injury by regulating the PI3K-Akt pathway in rats. PloS One 9: e104043.CrossRefPubMedPubMedCentral Suo, L., K. Kang, X. Wang, Y. Cao, H. Zhao, X. Sun, L. Tong, and F. Zhang. 2014. Carvacrol alleviates ischemia reperfusion injury by regulating the PI3K-Akt pathway in rats. PloS One 9: e104043.CrossRefPubMedPubMedCentral
28.
go back to reference Feng, X., and A. Jia. 2014. Protective effect of carvacrol on acute lung injury induced by lipopolysaccharide in mice. Inflammation 37: 1091–1101.CrossRefPubMed Feng, X., and A. Jia. 2014. Protective effect of carvacrol on acute lung injury induced by lipopolysaccharide in mice. Inflammation 37: 1091–1101.CrossRefPubMed
29.
Metadata
Title
Effects of Carvacrol on Survival, Mesenteric Blood Flow, Aortic Function and Multiple Organ Injury in a Murine Model of Polymicrobial Sepsis
Authors
Erdem Kamil Ozer
Mustafa Tugrul Goktas
Aysun Toker
Hulagu Bariskaner
Ceyhan Ugurluoglu
Alper Bektas Iskit
Publication date
01-10-2017
Publisher
Springer US
Published in
Inflammation / Issue 5/2017
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-017-0605-6

Other articles of this Issue 5/2017

Inflammation 5/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.